SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3586Even LOXO, whose data was stellar and soundly thumped Roche's competing progtuck-10/22/2018
3585ESMO-presenting companies are selling off left and right: investorshub.advfn.comDewDiligence_on_SI-10/22/2018
3584CLVS off 18% after ESMO, continuing a long slide over the last year or so. I thtuck-10/22/2018
3583LGND continue to slide,... turn-around target now may be 150-160????Miljenko Zuanic-10/19/2018
3582RE:LGND It is on decline mode, from ~280 toward <200. Any-One with idea, whaMiljenko Zuanic-10/17/2018
3581>> Urinalist is more apropos. << Just goes on and on and on and on.scaram(o)uche-9/27/2018
3580Geron (GERN) off 68% pre-market as J&J a bit belatedly returns the lead progtuck-9/27/2018
3579Looks like mdgl has a chance of making it back below 200. Tempting given the tasemi_infinite -9/6/2018
3578SGMO: And the shellacking continues. You do not believe that a certain 'Biotech Jim-9/6/2018
3577sciencedirect.com Our data indicate that the transfected as well as the infecteBiotech Jim-9/6/2018
3576>> pissing in the wind << I had already seen Maxim's post at twscaram(o)uche-9/5/2018
3575>> I need to read up on IDS being taken up into cells. << Chuckle. scaram(o)uche-9/5/2018
3574I bought a starter position this morning on the sell off. The data looked promiBiotech Jim-9/5/2018
3573Agree. And in the interest of full disclosure, I am long as well. However, Iatticus4paws-9/5/2018
3572Thanks for that! GAG levels in urine are variable, and it's two patients. scaram(o)uche19/5/2018
3571I don't know the answer to that question but we only saw GAG reduction at thDaveAu19/5/2018
3570Max Jacobs on Twitter questioned urine concentration contribution, but I haven&#atticus4paws-9/5/2018
3569sgmo, sgmo, and sgmo..... off 23% at the moment..... no iduronate-2-sulfatascaram(o)uche-9/5/2018
3568Eidos (EIDX) off almost 40% on solid data from competing PFE program. EIDX is btuck-8/27/2018
3567Akebia (AKBA) off 17% post earnings. Don't follow it closely enough to knowtuck-8/9/2018
3566re: OVID (from DewDiligence) OVID -35% on questionable phase-2 data: forbes.Bladerunner17-8/6/2018
3565AXGN -15% – disappointment in Q2 report?tnsaf-8/2/2018
3564resTORbio (TORC) off 15% as analyst actually calls out spun data and downgrades(tuck18/1/2018
3563ENTA -15% on ABBV's HCV guidance for 3Q18/4Q18—i.e. investors' expectatiDewDiligence_on_SI-7/27/2018
3562Zynerba (ZYNE) off 25% (had been worse) on heavy discounted secondary. Might betuck-7/20/2018
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News